Skip to main content

Table 1 Patient’s demographic characteristics and initial COVID-19 severity data

From: Cluster analysis unveils a severe persistent respiratory impairment phenotype 3-months after severe COVID-19

Characteristic

 

Number of patients

62

Male

41 (63.1)

Age, years

63.0 ± 12.4

BMI, kg/m2

29.3 ± 5.7

Smoking history

 

 Current or ex-smoker

30 (48.4)

 Pack-years

36.3 ± 35.0

Comorbidities

 

 Obesity

21 (33.9)

 Diabetes mellitus

15 (24.2)

 Cardiovascular disease

37 (59.7)

 Arterial hypertension

32 (51.6)

 Immunodepression

4 (6.5)

 Respiratory chronic disease

 

  COPD

4 (6.5)

  Asthma

8 (12.9)

  Interstitial lung disease

1 (1.6)

 Inhaled corticosteroids

8 (12.9)

Covid-19

 

 Total length for hospital stay, days

19.5 [37.0]

 ICU, n

37 (59.7)

  ICU stay length, days

13.0 [13.5]

  High-flow nasal oxygen, n

34 (54.8)

  High-flow nasal oxygen, days

4.5 [6.0]

  Intubation, n

19 (30.6)

  Intubation, days

13.0 [20.0]

 Physical medicine and rehabilitation unit, n

23 (37.1)

 Complications

 

  ARDS

18 (29.0)

  Pulmonary embolism

9 (14.5)

  Ventilator-associated pneumonia

9 (14.5)

  Acute cardiac insufficiency

3 (4.8)

  Pneumothorax

2 (3.2)

  1. Data are expressed as numbers (percentages) or median [interquartile range]
  2. BMI: body mass index; COPD: Chronic Obstructive Pulmonary Disease; ICU: Intensive Care Unit; ARDS: Acute Respiratory Distress Syndrome